共 50 条
- [31] Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors.: Part 2:: Lead optimizationBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) : 4299 - 4304Xue, CBHe, XHRoderick, JCorbett, RLDuan, JJWLiu, RQCovington, MBQian, MXRibadeneira, MDVaddi, KChrist, DDNewton, RCTrzaskos, JMMagolda, RLWexler, RRDecicco, CP
- [32] The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidatesBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7164 - 7168Wang, Jane L.Aston, KarlLimburg, DavidLudwig, CindyHallinan, Ann E.Koszyk, FrancisHamper, BruceBrown, DavidGraneto, MatthewTalley, JohnMaziasz, TimothyMasferrer, JaimeCarter, Jeffery
- [33] Novel glycine transporter type-2 reuptake inhibitors.: Part 1:: α-amino acid derivativesBIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (16) : 4477 - 4492Wolin, RLVenkatesan, HTang, LSantillan, ABarclay, TWilson, SLee, DHLovenberg, TW
- [34] Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-pyridinylguanidinesBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (02) : 181 - 184Barber, CGDickinson, RPHorne, VA
- [35] N-Substituted unusual amino acids as corrosion inhibitors. Part IV: N-Acyl derivatives of unnatural amino acids with double bondINTERNATIONAL JOURNAL OF CORROSION AND SCALE INHIBITION, 2016, 5 (04): : 360 - 366Telegdi, J.
- [36] 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 330 - 333Argiriadi, Maria A.Ericsson, Anna M.Harris, Christopher M.Banach, David L.Borhani, David W.Calderwood, David J.Demers, Megan D.DiMauro, JenniferDixon, Richard W.Hardman, JenniferKwak, SilviaLi, BiqinMankovich, John A.Marcotte, DouglasMullen, Kelly D.Ni, BaofuPietras, M.Sadhukhan, RamkrishnaSousa, SilvinoTomlinson, Medha J.Wang, LuXiang, TaoTalanian, Robert V.
- [37] Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1696 - 1701Zhang, XYUrbanski, MPatel, MCox, GGZeck, REBian, HYConway, BRBeavers, MPRybczynski, PJDemarest, KT
- [38] HCV NS5A Replication Complex Inhibitors. Part 4. Optimization for Genotype la Replicon Inhibitory ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1976 - 1994St Laurent, Denis R.Serrano-Wu, Michael H.Belema, MakonenDing, MinFang, HuaGao, MinGoodrich, Jason T.Krause, Rudolph G.Lemm, Julie A.Liu, MengpingLopez, Omar D.Nguyen, Van N.Nower, Peter T.O'Boyle, Donald R., IIPearce, Bradley C.Romine, Jeffrey L.Valera, LourdesSun, Jin-HuaWang, Ying-KaiYang, FukangYang, XuejieMeanwell, Nicholas A.Snyder, Lawrence B.
- [39] Optimization of the iminohydantoin series of BACE-1 inhibitors. Part 5: Exploration of the S1′ and S2-S3 binding sitesABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238Smith, ElizabethIserloh, UlrichPan, JianpingHuang, YingLi, GuoqingCumming, JaredWang, LingyanVoigt, JohannesStrickland, CoreyKennedy, Matthew E.Chen, XiaKuvelkar, ReshmaFavoreau, LenardZhu, ZhaoningMcKittrick, BrianStamford, AndrewCzarniecki, MichaelParker, EricHunter, JohnGreenlee, William
- [40] A platform for designing HIV integrase inhibitors. Part 2: A two-metal binding model as a potential mechanism of HIV integrase inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) : 8420 - 8429Kawasuji, TakashiFuji, MasahiroYoshinaga, TomokazuSato, AkihikoFujiwara, TamioKiyama, Ryuichi